Angiography Imaging Systems Market Synopsis

Angiography Imaging Systems Market Size Was Valued at USD 13.06 Billion in 2023 and is Projected to Reach USD 21.56 Billion by 2032, Growing at a CAGR of 5.73% From 2024-2032.

Angiography Imaging Systemsare an automated process used to create rapid prototypes and functional end-use parts that have witnessed increasing demand from healthcare, automotive, and other industries globally Angiography imaging systems are medical devices used to visualize blood vessels in the body. These systems typically involve injecting a contrast dye into the bloodstream, which highlights the blood vessels on X-ray images or other imaging modalities such as CT scans or MRI scans.

• Angiography imaging systems are crucial in medical fields for visualizing blood vessels and blood flow within the body. They are used for diagnostic purposes to identify blockages, narrowing, or abnormalities in blood vessels, aiding in diagnosing conditions like coronary artery disease, peripheral artery disease, and cerebrovascular disease. They are also essential for guiding minimally invasive interventional procedures, such as angioplasty, stent placement, embolization, thrombolysis, and arterial catheterization.
• Angiography systems are also used in cardiology for cardiac catheterization, assessing coronary artery disease severity, and guiding interventions. They are also vital in neuro interventional radiology for diagnosing and treating brain and spinal cord conditions, such as aneurysms, arteriovenous malformations, and strokes. Angiography systems are also used in peripheral vascular imaging to assess blood flow and detect blockages in arteries and veins, aiding in diagnosing conditions like peripheral artery disease, deep vein thrombosis, and abdominal aortic aneurysms.
• The increasing incidence of cardiovascular diseases worldwide necessitates the use of diagnostic tools like angiography imaging systems. Technological advancements in medical imaging, such as improved image quality and minimally invasive procedures, have increased the demand for advanced systems. The aging population, prone to cardiovascular diseases, and rising healthcare expenditure also drive the demand for these systems. Increased awareness about early detection and screening programs has led to more people seeking diagnostic procedures.
• Emerging markets with improved healthcare infrastructure and rising disposable incomes are also driving demand for angiography systems. The trend towards minimally invasive procedures, such as CT and MRI, further increased the demand for angiography systems.

Angiography Imaging Systems Market Trend Analysis

Increasing Incidence of Cardiovascular Diseases

• Cardiovascular diseases encompass a range of conditions affecting the heart and blood vessels, including coronary artery disease, stroke, peripheral arterial disease, and others. These diseases collectively represent one of the leading causes of morbidity and mortality globally. Over the past few decades, steady increase in the prevalence of cardiovascular diseases worldwide. Factors contributing to this rise include sedentary lifestyles, unhealthy dietary habits, tobacco use, obesity, and increasing life expectancy.
• The burden of cardiovascular diseases places significant strain on healthcare systems, necessitating effective diagnostic and treatment strategies. Angiography imaging systems play a crucial role in the diagnosis and management of cardiovascular conditions by providing detailed images of blood vessels and identifying blockages, narrowing, or abnormalities. Accurate and timely diagnosis is critical for the effective management of cardiovascular diseases. Angiography imaging systems enable healthcare professionals to visualize the anatomy and function of blood vessels, aiding in the diagnosis of conditions such as coronary artery disease, peripheral artery disease, congenital heart defects, and aneurysms.
• Diagnosis and angiography imaging systems are used to guide various interventional procedures aimed at treating cardiovascular diseases. High-quality angiographic images are essential for precise catheter placement and real-time visualization during these procedures. Following diagnosis and intervention, angiography imaging systems are also utilized for patient management and follow-up care. Serial angiographic studies may be performed to monitor disease progression, assess treatment efficacy, and guide further therapeutic interventions as needed.
• The aging population demographic is particularly susceptible to cardiovascular diseases due to age-related changes in the cardiovascular system, such as arterial stiffness, atherosclerosis, and increased prevalence of comorbidities. As the global population continues to age, the incidence of cardiovascular diseases is expected to rise further, driving sustained demand for angiography imaging systems.

Restraints

Harmful Radiation Exposure

• The primary concern with angiography imaging systems is the potential for harmful radiation exposure to patients, clinicians, and medical staff. Prolonged or excessive exposure to ionizing radiation can increase the risk of various health issues, including cancer and genetic mutations. the radiation dose from a single angiography procedure may be relatively low, repeated or cumulative exposure over time can lead to significant health risks, particularly for patients undergoing multiple procedures or healthcare professionals routinely working with angiography systems.
• Ensuring patient safety is paramount in medical imaging. Healthcare providers must carefully balance the diagnostic benefits of angiography procedures with the potential risks associated with radiation exposure. Minimizing radiation dose while maintaining image quality is crucial to mitigating these risks. Healthcare professionals who operate angiography imaging systems are also at risk of radiation exposure. Without proper safety measures and protective equipment, such as lead aprons, thyroid shields, and radiation monitoring devices, medical staff may be vulnerable to the harmful effects of ionizing radiation.
• Radiation exposure can cause anxiety and concern among patients undergoing angiography procedures, particularly those who are sensitive to medical radiation or have existing health conditions. Healthcare providers should communicate effectively with patients, addressing their concerns and providing clear information about the benefits and risks of the procedure.

Opportunity Line Here

Integration with Artificial Intelligence

• AI algorithms can analyze angiography images more efficiently and accurately than traditional methods, aiding in the detection of subtle abnormalities or early signs of disease. This can lead to more precise diagnosis and treatment planning, ultimately improving patient outcomes. AI can automate routine tasks involved in angiography imaging analysis, such as image segmentation, feature extraction, and measurement, reducing the workload on healthcare professionals and potentially speeding up the diagnostic process.
• By analyzing large datasets of angiography images along with clinical data, AI can help tailor treatments to individual patients based on their unique characteristics and disease profiles. This personalized approach can optimize treatment efficacy and minimize adverse effects. Integrating AI with angiography systems enables real-time decision support for clinicians during procedures. AI algorithms can provide instant feedback on image quality, guide catheter placement, and assist in identifying optimal imaging parameters, improving procedural efficiency and safety.
• AI can help standardize imaging protocols and quality metrics across different healthcare facilities by providing automated quality assessment tools. This ensures consistency in image acquisition and interpretation, leading to more reliable and reproducible results. AI-powered angiography imaging systems facilitate research into novel imaging biomarkers, treatment strategies, and disease mechanisms. By analyzing vast amounts of imaging data, AI can uncover new insights that may lead to the development of innovative diagnostic and therapeutic approaches.

Challenges

High Cost and Accessibility

• Angiography imaging systems are sophisticated medical devices that require substantial initial investment for acquisition. The cost includes not only the equipment itself but also installation, training, maintenance, and potential upgrades. This high initial cost can be a significant barrier for healthcare facilities, particularly those in resource-constrained settings or smaller clinics with limited budgets. Beyond the initial purchase, angiography systems require regular maintenance and servicing to ensure optimal performance and longevity. These ongoing expenses can add up over time and may strain the financial resources of healthcare providers, particularly in regions where access to specialized technical support is limited.
• The operation of angiography systems involves additional expenses such as staff training, consumables, and utilities. These operational costs can further contribute to the overall financial burden associated with maintaining and using angiography systems. Angiography imaging systems are often concentrated in urban areas and regions with advanced healthcare infrastructure, leading to disparities in accessibility for individuals residing in rural or underserved areas. The lack of accessibility may result in delayed diagnosis and treatment for patients in these regions, exacerbating health inequalities.
• In some healthcare systems, reimbursement policies and financial coverage for angiography procedures may be insufficient, leading to financial strain for patients and healthcare providers alike. This can reduce the affordability of angiography imaging services and limit access for certain patient populations. Rapid advancements in medical imaging technology may lead to the obsolescence of older angiography systems, necessitating costly upgrades or replacements to maintain clinical standards. This challenge further exacerbates the financial burden associated with angiography imaging systems over their lifecycle

Angiography Imaging Systems Market Segment Analysis:

Angiography Imaging Systems Market Segmented based on technology, application, and end-users.

By Technology, X-ray Angiography segment is expected to dominate the market during the forecast period

• X-ray angiography is a standard and widely used imaging technique for visualizing blood vessels for many years. Its long history and established track record in clinical practice give it a strong foundation and widespread acceptance among healthcare providers. X-ray angiography offers real-time imaging capabilities, allowing clinicians to visualize blood flow dynamically during interventional procedures. This real-time feedback is crucial for guiding minimally invasive interventions such as angioplasty, stent placement, and embolization.
• X-ray angiography provides high spatial resolution images, enabling detailed visualization of vascular anatomy and pathology. This level of detail is essential for accurately diagnosing and treating various cardiovascular conditions, including coronary artery disease, peripheral artery disease, and cerebral vascular disorders. X-ray angiography plays a central role in interventional radiology and cardiology procedures. Its ability to guide catheter-based interventions in real-time makes it indispensable for treating a wide range of vascular diseases.
• While the initial investment for X-ray angiography equipment can be significant, its widespread adoption and established reimbursement mechanisms contribute to its overall cost-effectiveness. However, the high throughput and versatility of X-ray angiography systems make them valuable assets for healthcare facilities seeking to maximize resource utilization. X-ray angiography is utilized across a broad spectrum of clinical specialties, including cardiology, radiology, neurology, vascular surgery, and interventional oncology. Its versatility and applicability to diverse patient populations make it a versatile tool for diagnosing and treating various vascular disorders.

By Application, the Cardiology segment held the largest share of 41.34% in 2023

• Angiography imaging systems are extensively used in cardiology for diagnosing and treating peripheral vascular diseases, coronary artery diseases, and other cardiovascular conditions. These systems play a crucial role in procedures such as angioplasty, stent placement, embolization, and intravascular imaging. Given the high prevalence of cardiovascular diseases globally and the increasing adoption of minimally invasive interventions, the cardiology segment tends to hold the largest share of angiography imaging system utilization.
• Angiography imaging systems are integral to both the diagnosis and treatment of cardiovascular conditions. They provide detailed visualization of the coronary arteries, peripheral vasculature, and cardiac chambers, enabling clinicians to assess anatomical abnormalities, stenoses, and blockages. Furthermore, these systems guide minimally invasive procedures such as angioplasty, stent placement, and transcatheter valve interventions. The field of interventional cardiology witnessed significant advancements in recent decades, leading to a shift towards less invasive treatment approaches. Angiography imaging systems play a central role in these procedures by providing real-time visualization and guidance, thereby facilitating safer and more effective interventions.
• The rise of structural heart interventions, angiography imaging systems become indispensable tools for pre-procedural planning, intra-procedural guidance, and post-procedural assessment. The utilization of angiography imaging systems in cardiology is supported by established reimbursement mechanisms and clinical guidelines.

Angiography Imaging Systems Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast Period

• North America, particularly the United States boasts a highly developed healthcare infrastructure with sophisticated medical facilities, advanced technologies, and skilled healthcare professionals. This infrastructure supports the widespread adoption and utilization of angiography imaging systems in clinical practice. Cardiovascular diseases, including coronary artery disease, peripheral artery disease, and stroke, remain significant health concerns in North America. The region has a relatively high prevalence of these conditions, driving the demand for diagnostic and interventional procedures that rely on angiography imaging systems for accurate visualization and treatment guidance.
• North America is a global leader in medical technology innovation, with numerous research institutions, academic medical centers, and medical device companies driving advancements in imaging technologies, including angiography systems. This culture of innovation fosters the development and adoption of cutting-edge angiography imaging systems in the region. The United States, in particular, has a robust healthcare reimbursement system that often covers angiography procedures for diagnosing and treating cardiovascular diseases. This favorable reimbursement environment incentivizes healthcare providers to invest in angiography imaging systems and utilize them for a wide range of clinical applications.

Angiography Imaging Systems Market Top Key Players:

• GE Healthcare (US)
• Carestream Health (US)
• Hologic, Inc. (US)
• Konica Minolta Healthcare Americas, Inc. (US)
• Boston Scientific Corporation (US)
• Angiodynamics, Inc. (US)
• Stryker Corporation (US)
• Siemens Healthineers (Germany)
• Ziehm Imaging (Germany)
• B. Braun Melsungen AG (Germany)
• Smiths Group plc (UK)
• Philips Healthcare (Netherlands)
• Esaote SpA (Italy)
• Medtronic plc (Ireland)
• Agfa-Gevaert Group (Belgium)
• Mindray Medical International Limited (China)
• Canon Medical Systems Corporation (Japan)
• Shimadzu Corporation (Japan)
• Hitachi Healthcare (Japan)
• Toshiba Medical Systems Corporation (Japan)
• Fujifilm Medical Systems (Japan)
• Terumo Corporation (Japan)
• Nipro Corporation (Japan)
• Samsung Medison (South Korea), and other major players

Key Industry Developments in the Angiography Imaging Systems Market:

• In January 2024, GE HealthCare announced it acquired MIM Software, a global provider of medical imaging analysis and artificial intelligence (AI) solutions for the practice of radiation oncology, molecular radiotherapy, diagnostic imaging, and urology at imaging centers, hospitals, specialty clinics, and research organizations worldwide. GE HealthCare expects to leverage MIM Software’s imaging analytics and digital workflow capabilities across various care areas to accelerate innovation and differentiate its solutions for the benefit of patients and healthcare systems around the world.
• In January 2024, Carestream Health launched a new and enhanced DRX-Excel Plus X-ray System that boosts the performance of the powerful, two-in-one solution to enable more productivity and efficiency, higher image quality, and an improved experience for users and patients. Carestream’s DRX-Excel Plus X-ray System is a flexible solution for both fluoroscopy and general radiology that can deliver real-time, high-quality images for a wide range of exams while providing important features that help create an enhanced experience for users, patients, and administrators.

1. INTRODUCTION
   1. RESEARCH OBJECTIVES
   2. RESEARCH METHODOLOGY
   3. RESEARCH PROCESS
   4. SCOPE AND COVERAGE
      1. Market Definition
      2. Key Questions Answered
   5. MARKET SEGMENTATION
2. EXECUTIVE SUMMARY
3. MARKET OVERVIEW
4. GROWTH OPPORTUNITIES BY SEGMENT
5. MARKET LANDSCAPE
   1. PORTER’S FIVE FORCES ANALYSIS
      1. Bargaining Power Of Supplier
      2. Threat Of New Entrants
      3. Threat Of Substitutes
      4. Competitive Rivalry
      5. Bargaining Power Among Buyers
   2. INDUSTRY VALUE CHAIN ANALYSIS
   3. MARKET DYNAMICS
      1. Drivers
      2. Restraints
      3. Opportunities
      4. Challenges
   4. MARKET TREND ANALYSIS
   5. REGULATORY LANDSCAPE
   6. PESTLE ANALYSIS
   7. PRICE TREND ANALYSIS
   8. PATENT ANALYSIS
   9. TECHNOLOGY EVALUATION
   10. MARKET IMPACT OF THE RUSSIA-UKRAINE WAR
       1. Geopolitical Market Disruptions
       2. Supply Chain Disruptions
       3. Instability in Emerging Markets
   11. ECOSYSTEM
6. ANGIOGRAPHY IMAGING SYSTEMS MARKET BY TECHNOLOGY (2017-2032)
   1. ANGIOGRAPHY IMAGING SYSTEMS MARKET SNAPSHOT AND GROWTH ENGINE
   2. MARKET OVERVIEW
   3. X-RAY ANGIOGRAPHY
      1. Introduction And Market Overview
      2. Historic and Forecasted Market Size in Value (2017 – 2032F)
      3. Historic And Forecasted Market Size in Volume (2017 – 2032F)
      4. Key Market Trends, Growth Factors And Opportunities
      5. Geographic Segmentation Analysis
   4. CT ANGIOGRAPHY
   5. MRI ANGIOGRAPHY
   6. MR-CT ANGIOGRAPHY
7. ANGIOGRAPHY IMAGING SYSTEMS MARKET BY APPLICATION (2017-2032)
   1. ANGIOGRAPHY IMAGING SYSTEMS MARKET SNAPSHOT AND GROWTH ENGINE
   2. MARKET OVERVIEW
   3. CARDIOLOGY
      1. Introduction And Market Overview
      2. Historic And Forecasted Market Size in Value (2017 – 2032F)
      3. Historic And Forecasted Market Size in Volume (2017 – 2032F)
      4. Key Market Trends, Growth Factors And Opportunities
      5. Geographic Segmentation Analysis
   4. ONCOLOGY
   5. NEUROLOGY
   6. PERIPHERAL AND VASCULAR INTERVENTION
8. ANGIOGRAPHY IMAGING SYSTEMS MARKET BY END-USER (2017-2032)
   1. ANGIOGRAPHY IMAGING SYSTEMS MARKET SNAPSHOT AND GROWTH ENGINE
   2. MARKET OVERVIEW
   3. HOSPITALS
      1. Introduction And Market Overview
      2. Historic And Forecasted Market Size in Value (2017 – 2032F)
      3. Historic And Forecasted Market Size in Volume (2017 – 2032F)
      4. Key Market Trends, Growth Factors And Opportunities
      5. Geographic Segmentation Analysis
   4. AMBULATORY SURGICAL CENTERS
   5. DIAGNOSTIC CENTERS
9. COMPANY PROFILES AND COMPETITIVE ANALYSIS
   1. COMPETITIVE LANDSCAPE
      1. Competitive Positioning
      2. Angiography Imaging Systems Market Share By Manufacturer (2023)
      3. Industry BCG Matrix
      4. Heat Map Analysis
      5. Mergers & Acquisitions
   2. GE HEALTHCARE (US)
      1. Company Overview
      2. Key Executives
      3. Company Snapshot
      4. Role of the Company in the Market
      5. Sustainability and Social Responsibility
      6. Operating Business Segments
      7. Product Portfolio
      8. Business Performance (Production Volume, Sales Volume, Sales Margin, Production Capacity, Capacity Utilization Rate)
      9. Key Strategic Moves And Recent Developments
      10. SWOT Analysis
   3. CARESTREAM HEALTH (US)
   4. HOLOGIC, INC. (US)
   5. KONICA MINOLTA HEALTHCARE AMERICAS, INC. (US)
   6. HOLOGIC, INC. (US)
   7. BOSTON SCIENTIFIC CORPORATION (US)
   8. ANGIODYNAMICS, INC. (US)
   9. STRYKER CORPORATION (US)
   10. SIEMENS HEALTHINEERS (GERMANY)
   11. ZIEHM IMAGING (GERMANY)
   12. B. BRAUN MELSUNGEN AG (GERMANY)
   13. SMITHS GROUP PLC (UK)
   14. PHILIPS HEALTHCARE (NETHERLANDS)
   15. ESAOTE SPA (ITALY)
   16. MEDTRONIC PLC (IRELAND)
   17. AGFA-GEVAERT GROUP (BELGIUM)
   18. MINDRAY MEDICAL INTERNATIONAL LIMITED (CHINA)
   19. CANON MEDICAL SYSTEMS CORPORATION (JAPAN)
   20. SHIMADZU CORPORATION (JAPAN)
   21. HITACHI HEALTHCARE (JAPAN)
   22. TOSHIBA MEDICAL SYSTEMS CORPORATION (JAPAN)
   23. FUJIFILM MEDICAL SYSTEMS (JAPAN)
   24. TERUMO CORPORATION (JAPAN)
   25. NIPRO CORPORATION (JAPAN)
   26. SAMSUNG MEDISON (SOUTH KOREA)
10. GLOBAL ANGIOGRAPHY IMAGING SYSTEMS MARKET BY REGION
    1. OVERVIEW
    2. NORTH AMERICA
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Technology
       4. Historic And Forecasted Market Size By Application
       5. Historic And Forecasted Market Size By End User
       6. Historic And Forecasted Market Size By Country
          1. USA
          2. Canada
          3. Mexico
    3. EASTERN EUROPE
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Segments
       4. Historic And Forecasted Market Size By Country
          1. Russia
          2. Bulgaria
          3. The Czech Republic
          4. Hungary
          5. Poland
          6. Romania
          7. Rest Of Eastern Europe
    4. WESTERN EUROPE
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Segments
       4. Historic And Forecasted Market Size By Country
          1. Germany
          2. United Kingdom
          3. France
          4. The Netherlands
          5. Italy
          6. Spain
          7. Rest Of Western Europe
    5. ASIA PACIFIC
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Segments
       4. Historic And Forecasted Market Size By Country
          1. China
          2. India
          3. Japan
          4. South Korea
          5. Malaysia
          6. Thailand
          7. Vietnam
          8. The Philippines
          9. Australia
          10. New-Zealand
          11. Rest Of APAC
    6. MIDDLE EAST & AFRICA
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Segments
       4. Historic And Forecasted Market Size By Country
          1. Turkey
          2. Bahrain
          3. Kuwait
          4. Saudi Arabia
          5. Qatar
          6. UAE
          7. Israel
          8. South Africa
    7. SOUTH AMERICA
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Segments
       4. Historic And Forecasted Market Size By Country
          1. Brazil
          2. Argentina
          3. Rest of South America
11. INVESTMENT ANALYSIS
12. ANALYST VIEWPOINT AND CONCLUSION
    1. Recommendations and Concluding Analysis
    2. Potential Market Strategies

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. ANGIOGRAPHY IMAGING SYSTEMS MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. ANGIOGRAPHY IMAGING SYSTEMS MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. ANGIOGRAPHY IMAGING SYSTEMS MARKET COMPETITIVE RIVALRY
TABLE 005. ANGIOGRAPHY IMAGING SYSTEMS MARKET THREAT OF NEW ENTRANTS
TABLE 006. ANGIOGRAPHY IMAGING SYSTEMS MARKET THREAT OF SUBSTITUTES
TABLE 007. ANGIOGRAPHY IMAGING SYSTEMS MARKET BY TYPE
TABLE 008. X-RAY ANGIOGRAPHY MARKET OVERVIEW (2016-2028)
TABLE 009. MRI ANGIOGRAPHY MARKET OVERVIEW (2016-2028)
TABLE 010. CT ANGIOGRAPHY MARKET OVERVIEW (2016-2028)
TABLE 011. MR-CT ANGIOGRAPHY MARKET OVERVIEW (2016-2028)
TABLE 012. ANGIOGRAPHY IMAGING SYSTEMS MARKET BY APPLICATION
TABLE 013. CARDIOLOGY MARKET OVERVIEW (2016-2028)
TABLE 014. NEUROLOGY MARKET OVERVIEW (2016-2028)
TABLE 015. ONCOLOGY MARKET OVERVIEW (2016-2028)
TABLE 016. VASCULAR MARKET OVERVIEW (2016-2028)
TABLE 017. PERIPHERAL INTERVENTION MARKET OVERVIEW (2016-2028)
TABLE 018. ANGIOGRAPHY IMAGING SYSTEMS MARKET BY END-USER
TABLE 019. HOSPITALS MARKET OVERVIEW (2016-2028)
TABLE 020. DIAGNOSTIC & IMAGING CENTERS MARKET OVERVIEW (2016-2028)
TABLE 021. AMBULATORY SURGICAL CENTERS (ACCS) MARKET OVERVIEW (2016-2028)
TABLE 022. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 023. NORTH AMERICA ANGIOGRAPHY IMAGING SYSTEMS MARKET, BY TYPE (2016-2028)
TABLE 024. NORTH AMERICA ANGIOGRAPHY IMAGING SYSTEMS MARKET, BY APPLICATION (2016-2028)
TABLE 025. NORTH AMERICA ANGIOGRAPHY IMAGING SYSTEMS MARKET, BY END-USER (2016-2028)
TABLE 026. N ANGIOGRAPHY IMAGING SYSTEMS MARKET, BY COUNTRY (2016-2028)
TABLE 027. EUROPE ANGIOGRAPHY IMAGING SYSTEMS MARKET, BY TYPE (2016-2028)
TABLE 028. EUROPE ANGIOGRAPHY IMAGING SYSTEMS MARKET, BY APPLICATION (2016-2028)
TABLE 029. EUROPE ANGIOGRAPHY IMAGING SYSTEMS MARKET, BY END-USER (2016-2028)
TABLE 030. ANGIOGRAPHY IMAGING SYSTEMS MARKET, BY COUNTRY (2016-2028)
TABLE 031. ASIA PACIFIC ANGIOGRAPHY IMAGING SYSTEMS MARKET, BY TYPE (2016-2028)
TABLE 032. ASIA PACIFIC ANGIOGRAPHY IMAGING SYSTEMS MARKET, BY APPLICATION (2016-2028)
TABLE 033. ASIA PACIFIC ANGIOGRAPHY IMAGING SYSTEMS MARKET, BY END-USER (2016-2028)
TABLE 034. ANGIOGRAPHY IMAGING SYSTEMS MARKET, BY COUNTRY (2016-2028)
TABLE 035. MIDDLE EAST & AFRICA ANGIOGRAPHY IMAGING SYSTEMS MARKET, BY TYPE (2016-2028)
TABLE 036. MIDDLE EAST & AFRICA ANGIOGRAPHY IMAGING SYSTEMS MARKET, BY APPLICATION (2016-2028)
TABLE 037. MIDDLE EAST & AFRICA ANGIOGRAPHY IMAGING SYSTEMS MARKET, BY END-USER (2016-2028)
TABLE 038. ANGIOGRAPHY IMAGING SYSTEMS MARKET, BY COUNTRY (2016-2028)
TABLE 039. SOUTH AMERICA ANGIOGRAPHY IMAGING SYSTEMS MARKET, BY TYPE (2016-2028)
TABLE 040. SOUTH AMERICA ANGIOGRAPHY IMAGING SYSTEMS MARKET, BY APPLICATION (2016-2028)
TABLE 041. SOUTH AMERICA ANGIOGRAPHY IMAGING SYSTEMS MARKET, BY END-USER (2016-2028)
TABLE 042. ANGIOGRAPHY IMAGING SYSTEMS MARKET, BY COUNTRY (2016-2028)
TABLE 043. CANON MEDICAL SYSTEMS (JAPAN): SNAPSHOT
TABLE 044. CANON MEDICAL SYSTEMS (JAPAN): BUSINESS PERFORMANCE
TABLE 045. CANON MEDICAL SYSTEMS (JAPAN): PRODUCT PORTFOLIO
TABLE 046. CANON MEDICAL SYSTEMS (JAPAN): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 046. GE HEALTHCARE (US): SNAPSHOT
TABLE 047. GE HEALTHCARE (US): BUSINESS PERFORMANCE
TABLE 048. GE HEALTHCARE (US): PRODUCT PORTFOLIO
TABLE 049. GE HEALTHCARE (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 049. KONINKLIJKE PHILIPS N.V. (NETHERLANDS): SNAPSHOT
TABLE 050. KONINKLIJKE PHILIPS N.V. (NETHERLANDS): BUSINESS PERFORMANCE
TABLE 051. KONINKLIJKE PHILIPS N.V. (NETHERLANDS): PRODUCT PORTFOLIO
TABLE 052. KONINKLIJKE PHILIPS N.V. (NETHERLANDS): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 052. SIEMENS HEALTHINEERS (GERMANY): SNAPSHOT
TABLE 053. SIEMENS HEALTHINEERS (GERMANY): BUSINESS PERFORMANCE
TABLE 054. SIEMENS HEALTHINEERS (GERMANY): PRODUCT PORTFOLIO
TABLE 055. SIEMENS HEALTHINEERS (GERMANY): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 055. BOSTON SCIENTIFIC CORPORATION (US): SNAPSHOT
TABLE 056. BOSTON SCIENTIFIC CORPORATION (US): BUSINESS PERFORMANCE
TABLE 057. BOSTON SCIENTIFIC CORPORATION (US): PRODUCT PORTFOLIO
TABLE 058. BOSTON SCIENTIFIC CORPORATION (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 058. CORDIS CORPORATION (US): SNAPSHOT
TABLE 059. CORDIS CORPORATION (US): BUSINESS PERFORMANCE
TABLE 060. CORDIS CORPORATION (US): PRODUCT PORTFOLIO
TABLE 061. CORDIS CORPORATION (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 061. ANGIODYNAMICS (US): SNAPSHOT
TABLE 062. ANGIODYNAMICS (US): BUSINESS PERFORMANCE
TABLE 063. ANGIODYNAMICS (US): PRODUCT PORTFOLIO
TABLE 064. ANGIODYNAMICS (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 064. OMEGA MEDICAL IMAGING LLC (US): SNAPSHOT
TABLE 065. OMEGA MEDICAL IMAGING LLC (US): BUSINESS PERFORMANCE
TABLE 066. OMEGA MEDICAL IMAGING LLC (US): PRODUCT PORTFOLIO
TABLE 067. OMEGA MEDICAL IMAGING LLC (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 067. SHIMADZU CORPORATION (JAPAN): SNAPSHOT
TABLE 068. SHIMADZU CORPORATION (JAPAN): BUSINESS PERFORMANCE
TABLE 069. SHIMADZU CORPORATION (JAPAN): PRODUCT PORTFOLIO
TABLE 070. SHIMADZU CORPORATION (JAPAN): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 070. MEDTRONIC (IRELAND): SNAPSHOT
TABLE 071. MEDTRONIC (IRELAND): BUSINESS PERFORMANCE
TABLE 072. MEDTRONIC (IRELAND): PRODUCT PORTFOLIO
TABLE 073. MEDTRONIC (IRELAND): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 073. BRAUN MELSUNGEN (GERMANY): SNAPSHOT
TABLE 074. BRAUN MELSUNGEN (GERMANY): BUSINESS PERFORMANCE
TABLE 075. BRAUN MELSUNGEN (GERMANY): PRODUCT PORTFOLIO
TABLE 076. BRAUN MELSUNGEN (GERMANY): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 076. ABBOTT LABORATORIES (US): SNAPSHOT
TABLE 077. ABBOTT LABORATORIES (US): BUSINESS PERFORMANCE
TABLE 078. ABBOTT LABORATORIES (US): PRODUCT PORTFOLIO
TABLE 079. ABBOTT LABORATORIES (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 079. TERUMO (JAPAN): SNAPSHOT
TABLE 080. TERUMO (JAPAN): BUSINESS PERFORMANCE
TABLE 081. TERUMO (JAPAN): PRODUCT PORTFOLIO
TABLE 082. TERUMO (JAPAN): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 082. OTHER MAJOR PLAYERS: SNAPSHOT
TABLE 083. OTHER MAJOR PLAYERS: BUSINESS PERFORMANCE
TABLE 084. OTHER MAJOR PLAYERS: PRODUCT PORTFOLIO
TABLE 085. OTHER MAJOR PLAYERS: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. ANGIOGRAPHY IMAGING SYSTEMS MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. ANGIOGRAPHY IMAGING SYSTEMS MARKET OVERVIEW BY TYPE
FIGURE 012. X-RAY ANGIOGRAPHY MARKET OVERVIEW (2016-2028)
FIGURE 013. MRI ANGIOGRAPHY MARKET OVERVIEW (2016-2028)
FIGURE 014. CT ANGIOGRAPHY MARKET OVERVIEW (2016-2028)
FIGURE 015. MR-CT ANGIOGRAPHY MARKET OVERVIEW (2016-2028)
FIGURE 016. ANGIOGRAPHY IMAGING SYSTEMS MARKET OVERVIEW BY APPLICATION
FIGURE 017. CARDIOLOGY MARKET OVERVIEW (2016-2028)
FIGURE 018. NEUROLOGY MARKET OVERVIEW (2016-2028)
FIGURE 019. ONCOLOGY MARKET OVERVIEW (2016-2028)
FIGURE 020. VASCULAR MARKET OVERVIEW (2016-2028)
FIGURE 021. PERIPHERAL INTERVENTION MARKET OVERVIEW (2016-2028)
FIGURE 022. ANGIOGRAPHY IMAGING SYSTEMS MARKET OVERVIEW BY END-USER
FIGURE 023. HOSPITALS MARKET OVERVIEW (2016-2028)
FIGURE 024. DIAGNOSTIC & IMAGING CENTERS MARKET OVERVIEW (2016-2028)
FIGURE 025. AMBULATORY SURGICAL CENTERS (ACCS) MARKET OVERVIEW (2016-2028)
FIGURE 026. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 027. NORTH AMERICA ANGIOGRAPHY IMAGING SYSTEMS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 028. EUROPE ANGIOGRAPHY IMAGING SYSTEMS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 029. ASIA PACIFIC ANGIOGRAPHY IMAGING SYSTEMS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 030. MIDDLE EAST & AFRICA ANGIOGRAPHY IMAGING SYSTEMS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 031. SOUTH AMERICA ANGIOGRAPHY IMAGING SYSTEMS MARKET OVERVIEW BY COUNTRY (2016-2028)